Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Becker Muscular Dystrophy - Overview
Becker Muscular Dystrophy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Becker Muscular Dystrophy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Becker Muscular Dystrophy - Companies Involved in Therapeutics Development
Armgo Pharma Inc
Catabasis Pharmaceuticals Inc
Edgewise Therapeutics
Epirium Bio Inc
Italfarmaco SpA
Milo Biotechnology LLC
PTC Therapeutics Inc
ReveraGen BioPharma Inc
Sarcomed AB
Stealth BioTherapeutics Corp
Tivorsan Pharmaceuticals Inc
Becker Muscular Dystrophy - Drug Profiles
ARM-210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ataluren - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dextro epicatechin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
edasalonexent - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EDG-5506 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Becker Muscular Dystrophy - Dormant Projects
Becker Muscular Dystrophy - Discontinued Products
Becker Muscular Dystrophy - Product Development Milestones
Featured News & Press Releases
Aug 12, 2020: Epirium Bio announces commencement of phase 1 clinical trial of EPM-01 in Becker muscular dystrophy
Apr 14, 2020: Epirium Bio receives FDA orphan-drug desigtion for EB 002 ((+)-Epicatechin) for the treatment of duchenne and becker muscular dystrophy
Feb 10, 2016: Catabasis Pharmaceuticals Will Present CAT-1004, a Potential Disease-Modifying Agent in Development for the Treatment of Duchenne Muscular Dystrophy, at the XIV Intertiol Conference on Duchenne and Becker Muscular Dystrophy
Jun 30, 2015: Cardero Therapeutics Presents at 2015 Parent Project Muscular Dystrophy Connect Conference
Mar 31, 2015: Cardero Therapeutics Presents at 2015 Muscular Dystrophy Association Scientific Conference
Sep 30, 2014: Becker Trial completed at UC-Davis on the Cardero Therapeutics lead compound
May 31, 2013: Becker Trial initiated at UC-Davis on the Cardero Therapeutics lead compound
Mar 31, 2013: Completed triglyceride trial with Cardero Therapeutics lead compound
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Becker Muscular Dystrophy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Becker Muscular Dystrophy, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Becker Muscular Dystrophy - Pipeline by Armgo Pharma Inc, H2 2020
Becker Muscular Dystrophy - Pipeline by Catabasis Pharmaceuticals Inc, H2 2020
Becker Muscular Dystrophy - Pipeline by Edgewise Therapeutics, H2 2020
Becker Muscular Dystrophy - Pipeline by Epirium Bio Inc, H2 2020
Becker Muscular Dystrophy - Pipeline by Italfarmaco SpA, H2 2020
Becker Muscular Dystrophy - Pipeline by Milo Biotechnology LLC, H2 2020
Becker Muscular Dystrophy - Pipeline by PTC Therapeutics Inc, H2 2020
Becker Muscular Dystrophy - Pipeline by ReveraGen BioPharma Inc, H2 2020
Becker Muscular Dystrophy - Pipeline by Sarcomed AB, H2 2020
Becker Muscular Dystrophy - Pipeline by Stealth BioTherapeutics Corp, H2 2020
Becker Muscular Dystrophy - Pipeline by Tivorsan Pharmaceuticals Inc, H2 2020
Becker Muscular Dystrophy - Dormant Projects, H2 2020
Becker Muscular Dystrophy - Discontinued Products, H2 2020